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Birt-Hogg-Dube´ syndrome (BHD), an inherited autosomal genodermatosis characterized by benign tumors of the
hair follicle, has been associated with renal neoplasia, lung cysts, and spontaneous pneumothorax. To identify the
BHD locus, we recruited families with cutaneous lesions and associated phenotypic features of the BHD syndrome.
We performed a genomewide scan in one large kindred with BHD and, by linkage analysis, localized the gene locus
to the pericentromeric region of chromosome 17p, with a LOD score of 4.98 at D17S740 (recombination fraction
0). Two-point linkage analysis of eight additional families with BHD produced a maximum LOD score of 16.06
at D17S2196. Haplotype analysis identified critical recombinants and defined the minimal region of nonrecom-
bination as being within a !4-cM distance between D17S1857 and D17S805. One additional family, which had
histologically proved fibrofolliculomas, did not show evidence of linkage to chromosome 17p, suggesting genetic
heterogeneity for BHD. The BHD locus lies within chromosomal band 17p11.2, a genomic region that, because
of the presence of low-copy-number repeat elements, is unstable and that is associated with a number of diseases.
Identification of the gene for BHD may reveal a new genetic locus responsible for renal neoplasia and for lung and
hair-follicle developmental defects.
In 1977, Birt, Hogg, and Dube´ described a kindred in
which 15 of 70 family members developed multiple,
small, white or skin-colored papules on the face, neck,
and upper trunk, after the age of 25 years (Birt et al.
1977). Histologic evaluation of the papules identified
anastomosing strands of epithelial cells emanating from
hair follicles surrounded by loose connective-tissue fibers
and mucin-rich stroma. These aberrant hamartomas of
the hair-follicle structure, called “fibrofolliculomas,”
were often found associated with trichodiscomas and
achrocordons (Cohen and Kurzrock 1995; Scalvenzi et
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al. 1998) and were inherited in an autosomal dominant
manner. This triad of dermatologic lesions has become
known as the “Birt-Hogg-Dube´ syndrome” (BHD). Sub-
sequent reports have described patients in which the cu-
taneous lesions of BHD are associated with renal tumors
(Roth et al. 1993; Toro et al. 1999), spontaneous pneu-
mothorax or lung cysts (Chung et al. 1996; Toro et al.
1999), and/or colonic polyps (Rongioletti et al. 1989).
To date, a genetic locus for BHD has not been identified.
As part of an ongoing study of families with inherited
renal cancer, we recently described a new type of inherited
renal neoplasia, familial renal oncocytoma (FRO), in five
families with multiple members affected with bilateral,
multiple renal oncocytomas (Weirich et al. 1998). On der-
matologic examination, 13 members of three of these five
families with FRO were found to have cutaneous BHD
lesions (Toro et al. 1999). Subsequently, through mass
mailings to dermatologists, we identified 33 families with
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Table 1
Two-Point LOD Scores for Chromosome 17p Markers in Family 172
MARKERa
LOD SCORE AT v p
Zmax (vmax).00 .01 .05 .10 .20 .30 .40
D17S918 1.74 1.30 1.77 1.77 1.44 .95 .39 1.77 (.05)
D17S953 3.18 3.11 2.81 2.43 1.65 .88 .23 3.18 (.00)
D17S740 4.98 4.88 4.50 4.00 2.96 1.88 .81 4.98 (.00)
D17S2196 4.07 3.99 3.69 3.30 2.49 1.66 .84 4.07 (.00)
D17S620 2.93 2.87 2.61 2.29 1.63 .97 .35 2.93 (.00)
D17S805 3.75 3.68 3.40 3.04 2.28 1.47 .61 3.75 (.00)
D17S2187 4.37 4.28 3.88 3.37 2.29 1.21 .33 4.37 (.00)
D17S1824 2.51 3.87 4.17 3.98 3.21 2.22 1.06 4.17 (.05)
a Order is from telomere to centromere and is based on the Marsh-
field map (see the Center for Medical Genetics, Marshfield Medical
Research Foundation web site).
BHD skin lesions and associated renal tumors, lung cysts
or pneumothorax, and/or colonic polyps, including the
original Canadian family (family 172) described by Birt
et al. (1977). In a separate study (B. Zbar, G. Alvord, G.
Glenn, M. Turner, C. Pavlovich, J. Toro, M. Merino, L.
Schmidt, M. Walther, P. Choyke, G. Weirich, S. Hewitt,
P. Duray, F. Gibril, C. Greenberg, and W. M. Linehan,
unpublished data), we have found evidence that BHD
confers an increased risk for the development of renal
tumors and lung cysts or spontaneous pneumothorax but
not for the development of colonic polyps. In the present
study, we used family 172 to perform an initial genome-
wide scan and two-point linkage analysis. We subse-
quently performed linkage analysis in an additional eight
families to identify the disease-gene locus for BHD.
Families with two or three generations of affected
members were recruited and evaluated on field trips and
at the National Institutes of Health (NIH) Clinical Cen-
ter. Skin and oral examinations were performed, and
skin lesions suspicious for fibrofolliculomas were biop-
sied for histology. Blood samples were taken for DNA
extraction by standard phenol/chloroform methods.
Screening of patients included renal ultrasound and ab-
dominal computed-tomography (CT) scan to detect re-
nal neoplasms, colonoscopy to detect colonic polyps,
high-resolution thoracic CT scan to detect air-filled lung
cysts (blebs), and standard chest CT and chest x-ray
examination to look for evidence of old or new pneu-
mothoraces. Histology of previously resected renal tu-
mors was reviewed and diagnosed according to criteria
established by the National Cancer Institute (NCI) Lab-
oratory of Pathology. Signed, informed consent was ob-
tained from all participants in the study, according to
the NCI institutional review board–approved protocol.
We chose family 172, a large three-generation family
with 18 affected members, for the initial genome scan.
Simulation of linkage was first performed to assess the
power of data on this pedigree to produce a LOD score
13.0 at a disease-linked locus. Linkage analysis with sim-
ulated genotyping data, forcing linkage between the dis-
ease locus and a hypothetical polymorphic marker locus,
produced a LOD score of 6.1 in family 172 (data not
shown). Subsequently, we performed a genomewide scan
in which 40 family members were genotyped with 185
polymorphic microsatellite markers (Dib et al. 1996), at
a resolution of 10–15 cM, covering 19 autosomal chro-
mosomes. Radiolabeled alleles were amplified from ge-
nomic DNA templates by PCR, separated on 6% poly-
acrylamide gels, exposed to x-ray films, and scored.
Two-point LOD scores were calculated with MLINK in
LINKAGE package version 5.1 (Lathrop et al. 1984) and
the low-penetrance model (i.e., 10% risk of development
of BHD at age 40 years and maximum [40%] risk at
age 140 years). Autosomal dominant inheritance was as-
sumed, with a gene frequency of .0001 and three liability
classes. Allele frequencies were estimated on the basis of
the genotypes of unrelated spouses. An individual was
considered to be affected when he or she displayed (a)
110 skin lesions with the clinical appearance of fibrofol-
liculoma and (b) a minimum of one histologically con-
firmed fibrofolliculoma. The affection status of asymp-
tomatic obligate carriers was considered to be unknown.
The results of the primary genomewide search for the
BHD-gene locus strongly supported linkage to chro-
mosome 17 in family 172. All of the 185 markers from
other regions of the genome gave LOD scores !1.2 at
a recombination fraction (v) of 0, with the exception of
four markers. The low heterozygosity of D1S1665,
D2S434, D9S915, and D8S1477 in family 172 gave
weakly positive LOD scores (0.18–0.83); in all cases,
however, negative LOD scores were obtained with mark-
ers immediately flanking these loci, ruling out linkage at
these sites. The BHD-gene candidate interval spanned
an 8.5-cM region located at chromosome 17p11.1-p12.
Two -point linkage analysis for six microsatellite mark-
ers gave LOD scores 12.9 when the low-penetrance
model was used (table 1). A maximum two-point LOD
score (Zmax) of 4.98 at a maximum v (vmax) of 0 was
obtained with marker D17S740. Recombinants were
identified at the flanking telomeric marker D17S918
(Zmax 1.77 at ) and the centromeric markerv p .05max
D17S1824 (Zmax 4.17 at ). Haplotype analysisv p .05max
(a) indicated that all individuals in family 172 who had
fibrofolliculomas shared the affected haplotype from
D17S953 to D17S2187 and (b) identified individuals IV-
9, IV-11, and III-8 as asymptomatic carriers of the BHD
haplotype (fig. 1). Individual III-8 is an obligate carrier
of the disease gene, since three of her children are af-
fected with fibrofolliculomas and have inherited the af-
fected haplotype (data not shown). For purposes of link-
age analysis, her affected status was considered to be
unknown. Changing the affected status of asymptomatic
haplotype carriers from unaffected to unknown raised
the LOD score for D17S740 to 5.25. LOD scores gen-
erated with the less-permissive, high-penetrance model
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Table 2
LOD Scores between BHD Locus and 17p11 Markers in Nine Families with BHD
MARKERa
DISTANCE
FROM pterb
(cM)
LOD SCORE AT v p
Zmax (vmax).00 .01 .05 .10 .20 .30 .40
D17S953 43.01 8.54 12.34 12.01 10.88 7.93 4.57 1.45 12.40 (.02)
D17S740 44.62 11.88 11.69 10.87 9.70 7.05 4.18 1.48 11.88 (.00)
D17S2196 44.62 16.06 15.81 14.77 13.30 9.94 6.19 2.48 16.06 (.00)
D17S620 47.00 8.96 8.79 8.05 7.09 5.03 2.93 1.02 8.96 (.00)
D17S805 47.00 3.68 6.99 7.28 6.89 5.41 3.47 1.38 7.29 (.03)
D17S1824 49.67 .11 10.82 11.88 11.34 8.94 5.76 2.42 11.88 (.05)
a Nonrecombining markers are underlined.
b Distance is based on the Marshfield map (see the Center for Medical Genetics, Marshfield Medical
Research Foundation web site).
(i.e., 40% risk of development of BHD at age40 years
of age and maximum [80%] risk at age 140 years) in-
creased for all six nonrecombinant markers (data not
shown).
Subsequently, we performed linkage analysis, using
the high-penetrance model, in eight additional families
with BHD, with the markers from chromosome 17p,
which cosegregated with BHD in family 172 (table 2).
For all nine families, a Zmax of 16.06 at wasv p 0max
obtained with the most informative marker, D17S2196.
When the affected status of asymptomatic haplotype
carriers was changed from unaffected to unknown, the
total LOD score increased to 19.17. Multipoint link-
age analysis performed with the VITESSE and FAST-
LINK programs (Cottingham et al. 1993; O’Connell et
al. 1995), using the high-penetrance model and data
from samples from all nine families, supported a disease-
locus location between flanking recombinant markers
D17S953 and D17S805, very near D17S2196, with a
LOD score of 22.44 at . (Intermarker distances re-vp 0
ported by Dib et al. [1996] are as follows: D17S953–
1.6 cM–D17S2196–2.4 cM–D17S805.)
Haplotype analysis of the eight additional families
with BHD showed that, within each family, all affected
individuals shared the family’s disease haplotype from
D17S918 to D17S1824 (data not shown), with two ex-
ceptions. An additional marker, D17S1857, was geno-
typed in these families, and two critical recombinants
were identified that narrowed the BHD-gene candidate
region. Individual III-4 in family 210 (fig. 2A) inherited
his family’s affected haplotype from D17S740 to
D17S1824 but had recombination between the disease
haplotype and the distal markers D17S918, D17S953,
and D17S1857. Individual II-5 in family 230 (fig. 2B)
inherited the affected haplotype of his affected family
members from D17S918 to D17S620 but had recom-
bination at D17S805, D17S689, and D17S1824. The
recombinants identified in families 210 and 230 nar-
rowed the region of the BHD-gene locus to a distance
of !4 cM, flanked by D17S1857 and D17S805 (fig. 3).
Linkage to chromosome 17p11 was established for all
families with BHD that were included in this study, except
for family 171, described previously by Toro et al. (1999).
Four members of this family were diagnosed with fibro-
folliculomas; however, linkage in this family was excluded
at chromosome 17p markers in the critical nonrecombi-
nant region: D17S2196 (LOD 3.13), D17S740 (LOD
2.89), D17S620 (LOD 3.0), D17S805 (LOD3.21),
and D17S1824 (LOD 6.79), suggesting genetic heter-
ogeneity for BHD. When we identify additional families
with BHD that do not show evidence of linkage to 17p,
we will perform a genomewide scan to search for addi-
tional BHD-gene loci.
Both low- and high-penetrance models were used for
the calculation of LOD scores in the nine families with
BHD; and significant Zmax values were obtained with both
models. The most suitable model for BHD appears to be
the high-penetrance model, in light of the fact that, in the
33 families with BHD that were recruited for our study,
88% (98/111) of family members of age 125 years who
carry the affected haplotype were positive for fibrofolli-
culomas (B. Zbar, G. Alvord, G. Glenn, M. Turner, C.
Pavlovich, J. Toro, M. Merino, L. Schmidt, M. Walther,
P. Choyke, G. Weirich, S. Hewitt, P. Duray, F. Gibril, C.
Greenberg, and W. M. Linehan, unpublished data). It is
of interest to note the variability of phenotypic expression
of this syndrome in the nine families with BHD. Although
a single gene defect is presumed to be inherited within
each family with BHD, phenotypic features within a fam-
ily varied from member to member—some individuals
harbored only cutaneous lesions, others had associated
renal tumors, and still others presented with pneumotho-
rax. Phenotypic heterogeneity within a family with BHD
suggests the involvement of other factors, such as modifier
genes and/or environmental factors, in the expression of
phenotype.
The region of linkage for the BHD locus—between
D17S1857 and D17S805, within chromosomal band
17p11.2—is the site of chromosomal breakpoints in
medulloblastomas (Seranski et al. 1999) and in primitive
Figure 2 Critical recombinants in families 210 and 230, which narrow the BHD nonrecombining region to !4.0 cM between D17S1857
and D17S805. A, Individual III-4 in family 210, who shows recombination at distal markers, D17S918, D17S953, and D17S1857 but shares
the proximal affected haplotype (D17S740–D17S1824) with affected family members. Individual III-7 is an obligate carrier with an affected
child, IV-3. Individual IV-2 is an asymptomatic carrier of the affected haplotype. B, Individual II-5 in family 230, who shares the distal affected
haplotype with affected family members but shows recombination at proximal markers D17S805, D17S689, and D17S1824. The affected son,
III-3, inherits the affected haplotype of his recombinant father. (For additional details, refer to the legend to fig. 1.)
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Figure 3 Ideogram of chromosome 17, showing genetic-map
location of microsatellite markers linked to the BHD locus. Map dis-
tances (in cM), from the 17p telomere, were obtained from the Marsh-
field map (see the Center for Medical Genetics, Marshfield Medical
Research Foundation web site). The BHD interval, determined on the
basis of recombination events, is flanked by D17S1857 and D17S805
(3.99 cM).
neuroectodermal tumors (Scheurlen et al. 1997). This
region is associated with the presence of complex repeat
elements, which cause the frequent occurrence of inter-
stitial deletions, duplications, and isochromosome for-
mation (Chen et al. 1997; Wilgenbus et al. 1997; Potocki
et al. 1999, 2000; Scheurlen et al. 1999), leading to mi-
crodeletion/duplication syndromes such as Smith-Ma-
genis syndrome (SMS) (for review, see Chen et al. 1996)
Using microsatellite and FISH analysis, we have begun
to evaluate renal tumors and lymphoblastoid cell lines
in patients with BHD, for interstitial deletions and DNA
rearrangements.
This region of chromosome 17p is very gene rich, with
130 known genes and many uncharacterized expressed-
sequence tags identified by the human-genome–se-
quencing effort and available from the Human Genome
Browser (version 4), maintained as the “Golden Path”
by University of California, Santa Cruz (see the UCSC
Human Genome Project Working Draft web site). Many
of these genes play a role in the regulation of either cell
proliferation and differentiation or carcinogenesis and,
therefore, are considered to be candidate genes for BHD.
They include lethal giant larvae, the human orthologue
of the Drosophila tumor-suppressor gene (Strand et al.
1995), flightless, the human orthologue of the Drosophi-
la gene (Chen et al. 1995), the gene for topoisomerase III,
the homologue of the yeast gene (Hanai et al. 1996), the
gene for subunit 3 of the COP9 signalosome, the gene for
part of a multiprotein complex involved in the ubiquitin-
proteosome pathway (Schwechheimer et al. 2001), and
two genes for Ras signaling-pathway molecules, Grb-
2–related adaptor protein (Feng et al. 1996) and Ran-
binding protein-1 (Bischoff et al. 1995). Housekeeping
genes in the region include those for serine hydroxyme-
thyltransferase (Elsea et al. 1995) and phosphatidyleth-
anolamine N-methyltransferase (Walkey et al. 1999).
Screening of these and other candidate genes from the
region of BHD linkage is in progress. Identification of the
locus for this genodermatosis will reveal a gene with a
novel role in kidney, lung, and hair-follicle development,
whose alteration can lead to renal neoplasia.
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